Cerebral and Tissue Oximetry Device Market Analysis

  • Report ID: 5837
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Cerebral and Tissue Oximetry Device Market Analysis

Application (Clinicals, Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Research Institutions)

Based on application, the hospital segment is predicted to account for 40% share of the global cerebral and tissue oximetry device market during forecast period 2024-2037. The market was led by hospitals, which were the main end users as they play a central role in patients' care and are responsible for managing critical conditions. In order to enhance real-time monitoring and allow healthcare professionals to make timely decisions, these medical facilities have adopted oximetry devices for cerebral and tissue. In particular in surgery and intensive care settings, these devices have proven to be an important element of ensuring the optimum oxygen level for patients.

Type (Portable, Desktop, Tabletop, Handheld)

In terms of type, the tabletop segment in cerebral and tissue oximetry device market is set to account for the highest CAGR of 60% by the end of 2037. The ease of use and accessibility is offered by Tabletop oximetry devices, which are placed in a convenient location on surfaces such as tables or counters. They are of particular benefit to healthcare professionals for their stable and proven ability to monitor oxygen levels in the brain and tissues. The widespread adoption of table top equipment in various healthcare settings is facilitated by user friendly interfaces and intuitive controls.

Our in-depth analysis of the global cerebral and tissue oximetry device market includes the following segments:

     Type

  • Portable
  • Desktop
  • Tabletop
  • Handheld

     Application

  • Clinicals
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  •  Research Institutions

     Technology

  • Near-Infrared Spectroscopy
  • Diffuse Optical Tomography

     End-User

  • Neonates
  • Adults
  • Pediatrics
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5837
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cerebral and tissue oximetry device is estimated at USD 249.2 million.

Cerebral and Tissue Oximetry Device Market size was valued at USD 237.06 million in 2024 and is set to cross USD 531.01 million by the end of 2037, expanding at more than 6.4% CAGR during the forecast period i.e., between 2025-2037. The growing technological advancement and increasing collaboration for research and development will drive the market growth.

North America industry is anticipated to hold largest revenue share of 35% by 2037, due to rising substantial prevalence of cardiovascular disease in the region.

The major players in the market are of Brain Scientific Inc., Masimo Corp., Medtronic Plc, Moor Instruments Ltd., Nihon Kohden Corporation, Sotera Health Co., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample